10x Genomics, Inc. v. Celsee, Inc.

CourtDistrict Court, D. Delaware
DecidedDecember 4, 2020
Docket1:19-cv-00862
StatusUnknown

This text of 10x Genomics, Inc. v. Celsee, Inc. (10x Genomics, Inc. v. Celsee, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
10x Genomics, Inc. v. Celsee, Inc., (D. Del. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE 10x GENOMICS, INC.,

Plaintiff, V. Civil Action No. 19-862-CFC CELSEE, INC.,

Defendant.

Frederick L. Cottrell, II, Jason J. Rawnsley, Alexandria M. Ewing, RICHARDS, LAYTON & FINGER, P.A., Wilmington, Delaware; Daralyn J. Durie, Eugene Novikov, Andrew L. Perito, Eneda Hoxha, Annie A. Lee, Ramsey W. Fisher, David F. McGowan, DURIE TANGRI LLP, San Francisco, California; Kira A. Davis, DURIE TANGRI LLP, Los Angeles, California Counsel for Plaintiff Brian E. Farnan, Michael J. Farnan, FARNAN LLP, Wilmington, Delaware; Barbara A. Fiacco, Jeremy A. Younkin, Brendan Jones, Emma S. Winer, Urszula Nowak, FOLEY HOAG LLP, Boston, Massachusetts Counsel for Defendant

MEMORANDUM OPINION

December 4, 2020 Wilmington, Delaware

CAG UNITED STATES DISTRICT JUDGE Plaintiff 10x Genomics Inc. has filed an objection to the Magistrate Judge’s denial of 10x’s motion to compel certain discovery. The Magistrate Judge had the authority to make this nondispositive ruling under 28 U.S.C. § 636(b)(1)(A). I “may reconsider” her ruling “where it has been shown that [it] .. . is clearly erroneous or contrary to law.” Jd. I exercise de novo review of the Magistrate Judge’s legal conclusions. AgroFresh Inc. v. Essentiv LLC, No. CV 16-662 (MN), 2019 WL 4917894, at *1 (D. Del. Oct. 4, 2019). I. The facts that led to the objection are straightforward. During the pendency of the case, nonparty Bio-Rad Laboratories acquired 100 percent of Defendant Celsee, Inc.’s stock pursuant to an acquisition agreement. The agreement, not surprisingly, has provisions related to this litigation. At two depositions, Celsee refused to let witnesses answer questions about documents Celsee disclosed to Bio- Rad and communications it had with Bio-Rad during the negotiations that resulted in the acquisition agreement. The disclosures and communications occurred after Celsee and Bio-Rad had signed a non-binding letter of intent to engage in the acquisition negotiations. Celsee cited the common interest privilege and the

attorney work product doctrine as the bases for its refusal to allow the witnesses to

answer the questions posed to them. D.I. 204-1, Ex. D at 73, Ex. G at 15-16. 10x asked the Magistrate Judge to order Celsee to reproduce one of the witnesses for no more than four hours of deposition and to compel that witness to produce and testify about any communications between Celsee and Bio-Rad concerning this litigation and the provisions in the acquisition agreement that

concern this litigation. D.I. 204 at 4. In its briefing before the Magistrate Judge, 10x represented that it “is not seeking” by this request “attorney files or mental impressions.” D.I. 204 at 4. Celsee argued in its briefing that its communications with Bio-Rad were protected from disclosure by the attorney work product doctrine and the common interest doctrine. D.I. 206 at 3-4. The Magistrate Judge agreed with Celsee that the information sought was protected from disclosure by both the common interest and attorney work product doctrines. Tr. of Sept. 23, 2020 Hr’g at 38:2-17. Accordingly, she denied 10x’s request for a compulsion order. 10x filed a timely objection to the Magistrate Judge’s ruling. I. On November 5, 2020, I heard oral argument and overruled 10x’s objection to the extent it sought to overturn the Magistrate Judge’s decision to deny 10x

access to Celsee’s attorneys’ work product. I made that ruling because Celsee had

represented to the Magistrate Judge that it was not seeking attorney mental impressions. See generally In re Cendant Corp. Secs. Litig., 343 F.3d 658, 667 (3d Cir. 2003) (holding that discovery of notes that reflect the impressions, opinion, and legal theories of counsel “goes to the core of the work product doctrine”). I reserved judgment on the issue of whether the common interest privilege protected Celsee’s communications with Bio-Rad from discovery and asked for further briefing on that issue by the parties. Having studied that briefing, the objection, the transcript of the ruling, Celsee’s response to the objection (D.I. 223), the parties’ briefing before the Magistrate Judge (D.I. 204; D.I. 206), and the cases cited by the parties, I have concluded that the communications at issue are not protected from disclosure by the common interest privilege and therefore will sustain the objection in part. A. The common interest privilege is an extension of the attorney-client privilege. It protects from discovery communications among clients and attorneys “allied in a common legal cause.” Jn re Regents of Univ. of Cal., 101 F.3d 1386, 1389 (Fed. Cir. 1996) (citation omitted). The privilege “applies in civil and criminal litigation, and even in purely transactional contexts.” In re Teleglobe Commc’ns Corp., 493 F.3d 345, 364 (3d Cir. 2007), as amended (Oct. 12, 2007) (citations omitted).

The common interest privilege and the common interest doctrine are two sides of the same coin. The common interest doctrine is defined as “an exception to the general rule that the attorney-client privilege will be waived following disclosure of privileged materials to a third party.” Corning Inc. v. SRU Biosystems LLC, 223 F.R.D. 189, 190 (D. Del. 2004) (citation omitted); see also Nidec Corp. v. Victor Co. of Japan, 249 F.R.D, 575, 578 (N.D. Cal. 2007) (“The joint defense and common interest doctrines are not privileges in and of themselves. Rather, they constitute exceptions to the rule on waiver where communications are disclosed to third parties.”). Whether described as an extension of the attorney-client privilege or an exception to the waiver of that privilege, the underlying principle—to protect the confidentiality of communications among attorneys and clients allied in a common legal cause—is the same. I will follow the Third Circuit’s lead in In re Teleglobe and use the term “common interest privilege.” The purpose of the attorney-client privilege, and by extension, the common interest privilege is to encourage full and frank communication between attorneys and their clients and thereby promote broader public interests in the observance of the law and administration of justice. The privilege recognizes that sound legal advice or advocacy serves public ends and that such advice or advocacy depends upon the lawyer's being fully informed by the client.

Upjohn Co. v. United States, 449 U.S. 383, 389 (1981). Like all privileges, the attorney-client privilege “is an exception to the common-law maxim that the public has a right to ‘every man’s evidence.’” In re Teleglobe Commce’ns Corp., 493 F.3d at 359-60 (citations omitted). Because the privilege “obstructs the truth-finding process, it is construed narrowly,” Westinghouse Elec. Corp. v. Republic of Philippines, 951 F.2d 1414, 1423 (3d Cir. 1991) (citations omitted), and “caution must be exercised to ensure that the privilege is contained within appropriate boundaries,” Union Carbide Corp. v Dow Chemical Co., 619 F. Supp. 1036, 1046 (D. Del. 1985) (citation omitted). In exercising that caution, a court should always be mindful of the privilege’s purpose. As the Third Circuit noted in Jn re Teleglobe, “{c]ommunication between counsel and client is not, in and of itself, the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Bryan
339 U.S. 323 (Supreme Court, 1950)
Trammel v. United States
445 U.S. 40 (Supreme Court, 1980)
Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
In Re the Regents of the University of California
101 F.3d 1386 (Federal Circuit, 1996)
In Re: Grand Jury v.
705 F.3d 133 (Third Circuit, 2012)
In Re Teleglobe Communications Corp.
493 F.3d 345 (Third Circuit, 2007)
Union Carbide Corp. v. Dow Chemical Co.
619 F. Supp. 1036 (D. Delaware, 1985)
Cavallaro v. United States
153 F. Supp. 2d 52 (D. Massachusetts, 2001)
Leader Technologies, Inc. v. Facebook, Inc.
719 F. Supp. 2d 373 (D. Delaware, 2010)
Libbey Glass, Inc. v. Oneida
197 F.R.D. 342 (N.D. Ohio, 1999)
Corning Inc. v. SRU Biosystems, LLC
223 F.R.D. 189 (D. Delaware, 2004)
In re Syncor Erisa Litigation
229 F.R.D. 636 (C.D. California, 2005)
Nidec Corp. v. Victor Co. of Japan
249 F.R.D. 575 (N.D. California, 2007)
Hewlett-Packard Co. v. Bausch & Lomb Inc.
115 F.R.D. 308 (N.D. California, 1987)
Griffith v. Davis
161 F.R.D. 687 (C.D. California, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
10x Genomics, Inc. v. Celsee, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/10x-genomics-inc-v-celsee-inc-ded-2020.